Literature DB >> 20182895

Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?

Roberto De Simone1, Angelo Ranieri, Chiara Fiorillo, Leonilda Bilo, Vincenzo Bonavita.   

Abstract

The association of chronic migraine (CM) with an idiopathic intracranial hypertension without papilledema (IIHWOP), although much more prevalent than expected in clinical series of CM sufferers, is not included among the risk factors for migraine progression. We discuss the available evidence supporting the existence of a pathogenetic link between CM and idiopathic intracranial hypertensive disorders and suggest a causative role for IIHWOP in migraine progression.

Entities:  

Mesh：

Year:  2010        PMID： 20182895     DOI： 10.1007/s10072-010-0229-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  59 in total

1.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

2.  Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures.

Authors:  I Ayzenberg; M Obermann; P Nyhuis; M Gastpar; V Limmroth; H C Diener; H Kaube; Z Katsarava
Journal:  Cephalalgia       Date:  2006-09       Impact factor: 6.292

3.  Transverse sinus stenoses persist after normalization of the CSF pressure in IIH.

Authors:  F Bono; C Giliberto; C Mastrandrea; D Cristiano; A Lavano; F Fera; A Quattrone
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

4.  Application of ICHD-II and revised diagnostic criteria to patients with chronic daily headache.

Authors:  E Sancisi; S Cevoli; G Pierangeli; S Zanigni; D Grimaldi; M Nicodemo; P Cortelli; P Montagna
Journal:  Neurol Sci       Date:  2007-03       Impact factor: 3.307

5.  Topiramate as an inhibitor of carbonic anhydrase isoenzymes.

Authors:  S J Dodgson; R P Shank; B E Maryanoff
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

6.  Cephalic venous congestion aggravates only migraine-type headaches.

Authors:  C-H Chou; A-C Chao; S-R Lu; H-H Hu; S-J Wang
Journal:  Cephalalgia       Date:  2004-11       Impact factor: 6.292

7.  Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine.

Authors:  D S S Vieira; M R Masruha; A L Gonçalves; E Zukerman; C A Senne Soares; M da Graça Naffah-Mazzacoratti; M F P Peres
Journal:  Cephalalgia       Date:  2008-03-31       Impact factor: 6.292

8.  Migraine aggravation caused by cephalic venous congestion.

Authors:  Florian Doepp; Stephan J Schreiber; Jens P Dreier; Karl M Einhäupl; José M Valdueza
Journal:  Headache       Date:  2003-02       Impact factor: 5.887

9.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

10.  Lateral sinus stenoses in idiopathic intracranial hypertension resolving after CSF diversion.

Authors:  J Nicholas P Higgins; John D Pickard
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910
View more
  13 in total

Review 1.  Sinus venous stenosis, intracranial hypertension and progression of primary headaches.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Mario Marchese; Pasquale Persico; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  Cerebral venous hemodynamic abnormalities in episodic and chronic migraine.

Authors:  B Petolicchio; A Viganò; Lazzaro di Biase; D Tatulli; M Toscano; E Vicenzini; F Passarelli; V Di Piero
Journal:  Funct Neurol       Date:  2016 Apr-Jun

3.  Letter to the editors: comment on "Emerging themes in idiopathic intracranial hypertension".

Authors:  Simona Toscano; Mario Zappia
Journal:  J Neurol       Date:  2021-01-20       Impact factor: 4.849

4.  Sinus venous stenosis-associated idiopathic intracranial hypertension without papilledema as a powerful risk factor for progression and refractoriness of headache.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Mario Marchese; Vincenzo Bonavita
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 5.  Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine.

Authors:  Roberto De Simone; Angelo Ranieri; Mattia Sansone; Enrico Marano; Cinzia Valeria Russo; Francesco Saccà; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2019-05       Impact factor: 3.307

6.  The prevalence of papilledema in patients with migraine: a crucial cooccurrence of migraine and idiopathic intracranial hypertension.

Authors:  Halil Onder; Ersin Kasim Ulusoy; Memet Aslanyavrusu; Tulin Akturk; Guven Arslan; Ibrahim Akkurt; Erol Erkan
Journal:  Neurol Sci       Date:  2020-05-26       Impact factor: 3.307

7.  Pseudotumor cerebri associated with modified Fontan anatomy.

Authors:  Hans Fuchs; Dhiraj Singh; Clarence Greene; Nancy Ross-Ascuitto; Robert Ascuitto
Journal:  Pediatr Cardiol       Date:  2012-08-17       Impact factor: 1.655

Review 8.  Is chronic migraine a primary or a secondary condition?

Authors:  Vincenzo Bonavita; Roberto De Simone
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

Review 9.  Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis.

Authors:  Roberto De Simone; Angelo Ranieri; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

10.  The lesson of chronic migraine.

Authors:  V Bonavita; R De Simone
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.